CDK12 mediates the inhibition effect of mechanical unloading on osteoblast proliferation by regulating RNAPII transcription activation Authors: Lifang Hu, Wenjin Zhong, Linlin Wang, Shujing Liang, Yunxian Jia, Zixiang Wu, Jingran Shen, Jiajun Sun, Airong Qian Published: 2026 ABSTRACT AimsMechanical stimuli are crucial in regulating normal osteoblast function to maintain bone homeostasis. Decreased osteoblast proliferation is one of the main causes of osteoporosis induced by mechanical unloading. However, the underlying mechanism remains unclear. Cyclin-dependent kinase 12 (CDK12), a member of the CDK family, plays a key role in regulating cell proliferation. In this study, we aimed to investigate the role of CDK12 in osteoblast proliferation, and its function and underlying mechanism in decreased osteoblast proliferation caused by mechanical unloading.MethodsCDK12 small interfering RNA (siRNA) and CDK12 plasmid were used to knock down and overexpress CDK12 in osteoblasts, respectively. 5-ethynyl-2´-deoxyuridine (EdU) staining, cell counting, and flow cytometry were adopted to detect the effects of mechanical unloading on osteoblast cell proliferation and cell cycle. Immunofluorescence staining was performed to detect the cellular localization of CDK12. Real-time polymerase chain reaction (PCR) and western blot were performed to analyze the expression of CDK12 and downstream molecules.ResultsMechanical unloading significantly reduced the EdU-positive cell ratio and the total cell number of primary osteoblasts, accompanied by a marked decrease of S phase cell percentage. Meanwhile, the expression of CDK12, a key regulator for cell cycle and cell proliferation, was significantly downregulated by mechanical unloading. Loss and gain of function studies revealed that CDK12 knockdown inhibits osteoblast proliferation and S phase cell cycle progression, while CDK12 overexpression increases these parameters. Moreover, mechanical unloading altered the subcellular localization of CDK12, reduced the phosphorylation level of RNA polymerase II (RNAPII), and downregulated the expression of key DNA replication genes, including CDC6, CDT1, ORC2, and TOPBP1. Similar results were obtained in CDK12 knockdown osteoblasts. Furthermore, CDK12 overexpression rescued the decreased osteoblast proliferation and reduced S phase percentage induced by mechanical unloading.ConclusionThe present study demonstrates CDK12 as a critical regulator of osteoblast proliferation under mechanical unloading conditions. Mechanistically, mechanical unloading suppresses osteoblast proliferation by downregulating CDK12 expression, which results in decreased RNAPII phosphorylation and reduced expression of downstream core DNA replication genes. These findings provide a novel mechanistic insight into the inhibitory effects of mechanical unloading on osteoblast proliferation, and reveals CDK12 as a novel potential target for treating disuse osteoporosis.Cite this article: Bone Joint Res 2026;15(7):914–926. Article focus How CDK12 functions in osteoblast proliferation under mechanical unloading conditions and the underlying mechanism. How CDK12 functions in osteoblast proliferation under mechanical unloading conditions and the underlying mechanism. Examination of the rescue effect of CDK12 overexpression on decreased osteoblast proliferation induced by mechanical unloading. Examination of the rescue effect of CDK12 overexpression on decreased osteoblast proliferation induced by mechanical unloading. Key messages CDK12 is critical in regulating decreased osteoblast proliferation induced by mechanical unloading. CDK12 is critical in regulating decreased osteoblast proliferation induced by mechanical unloading. CDK12 promotes osteoblast proliferation and cell cycle progression, and mediates the inhibition effect of mechanical unloading on osteoblast proliferation by regulating RNA polymerase II (RNAPII) transcription activation. CDK12 promotes osteoblast proliferation and cell cycle progression, and mediates the inhibition effect of mechanical unloading on osteoblast proliferation by regulating RNA polymerase II (RNAPII) transcription activation. CDK12 is a potential target for treating disuse osteoporosis. CDK12 is a potential target for treating disuse osteoporosis. Strengths and limitations To our knowledge, this study reveals for the first time the key role of CDK12 in osteoblast proliferation under mechanical unloading conditions, providing a basis for mechanical stimuli regulating osteoblast proliferation and a potential target for treating disuse osteoporosis. To our knowledge, this study reveals for the first time the key role of CDK12 in osteoblast proliferation under mechanical unloading conditions, providing a basis for mechanical stimuli regulating osteoblast proliferation and a potential target for treating disuse osteoporosis. The functional role of RNAPII in osteoblast proliferation needs further exploration. The functional role of RNAPII in osteoblast proliferation needs further exploration. Introduction Mechanical stimuli play a critical role in regulating bone remodelling to maintain normal mineral content and structure.1-3 Mechanical unloading in those who are bedridden, subject to prolonged immobilization, and/or long-term spaceflight leads to osteoporosis that seriously affects human health.4-7 It is imperative to uncover the molecular mechanism in order to provide a basis for effective treatment. Osteoblasts, the cells responsible for bone formation, play a key part in maintaining bone homeostasis. Accumulating evidence indicates that decreased osteoblast proliferation is a major cause of mechanical unloading-induced osteoporosis.8,9 However, the underlying mechanism of mechanical unloading inhibiting osteoblast proliferation is still unclear. Cyclin-dependent kinase 12 (CDK12), a member of the CDK family, plays a critical role in regulating cell proliferation and cell cycle.10-15 Lei et al14 found that knockdown of CDK12 prevented the assembly of prereplicative complex (pre-RC) in G1 phase and inhibited cell proliferation. CDK12/cyclin K knockdown inhibits cell proliferation and induces mitotic defects.13,16 Moreover, inhibition of CDK12 results in decreased cell proliferation.17-19 However, the role of CDK12 in osteoblast proliferation remains unknown, as well as whether CDK12 participates in the decreased osteoblast proliferation induced by mechanical unloading. In the present study, we first investigated the role of CDK12 in mechanical unloading inhibiting osteoblast proliferation and the underlying mechanism. Moreover, we aimed to determine the effect of CDK12 overexpression on decreased osteoblast proliferation caused by mechanical unloading. Methods Cell culture and transfection Both primary osteoblasts and osteoblast cell line MC3T3-E1 were adopted in this study. The primary osteoblasts were isolated from the cranium of one- to three-day old neonatal C57BL/6 mice. In brief, the calvaria was surgically isolated and washed with phosphate-buffered saline (PBS) to remove the surrounding tissue. Then, primary cells were released by five sequential ten-minute digestions with type II collagenase (Gibco; Thermo Fisher Scientific, USA) and dispase (Gibco). Cell populations from digestions 2 to 5 were collected and pooled (P2-5). Both the primary osteoblasts and MC3T3-E1 cells were cultured in α-minimum essential medium (α-MEM) (Gibco) containing 10% fetal bovine serum (FBS) (Biological Industries, Israel), 100 μg/ml streptomycin, and 100 units/ml penicillin. All cells were cultured in a humidified, 37°C, 5% CO2 incubator. Primary osteoblasts were used at passages 2 to 3, while MC3T3-E1 osteoblasts were used between passages 15 to 20. Specific cell types used for each experiment are indicated in the figure legends. To knockdown CDK12 in osteoblasts, MC3T3-E1 cells were transfected with CDK12-siRNA (Ribobio, China) and its corresponding control small interfering RNA (siRNA), respectively, by using Lipofectamine 2000 Reagent (Invitrogen; Thermo Fisher Scientific). To overexpress CDK12 in osteoblasts, cells were transfected with CDK12 plasmid (pEGFP-N1-CDK12) and the corresponding control plasmid (pEGFP-N1) respectively, (Sangon Biotech, China) by using Engreen Entranster H4000 transfection reagent (Engreen, China). Mechanical unloading condition The method has previously been reported in our studies.20-22 In brief, mechanical unloading condition was conducted by a random positioning machine (RPM, the centre for Space Science and Applied Research of Chinese Academy of Sciences).20-22 For mechanical unloading studies, cells were seeded on coverslips at a density of 8 × 104 cells/cm2, which were placed into cell culture flasks. To minimize the confounding effects of fluid shear stress, all the cell culture flasks were completely filled with cell culture media to exclude any air bubbles and fixed into the culture vessel of the RPM. The RPM was rotated randomly at a range of 0 to 10 rpm for 24 hours and 48 hours, respectively. Cells of the control group were cultured in the same incubator without rotation. EdU staining and cell counting for cell proliferation detection To determine the effects of mechanical unloading on cell proliferation, both 5-ethynyl-2'-deoxyuridine (EdU) staining and cell counting assay were performed. EdU staining of cells was performed using EdU staining kit (Ribobio) according to the manufacturer’s instruction. The nuclei were stained with Hoechst. After staining, the cells were observed under a fluorescence microscope (Zeiss, Germany; Observer 3) and the images were captured. The EdU positive cell ratio was calculated; the cell counting was conducted by a haemocytometer to obtain the total cell number of each group. Cell cycle analysis Cell cycle was determined by flow cytometry. The cells were prepared for flow cytometry analysis by using the cell cycle and apoptosis detection kit (Beyotime, China). Then, the cell cycle was determined by flow cytometry (FACS Calibur; BD Biosciences, USA) and the percentage of cells in the G1, S, and G2 phases was calculated using ModFit software (Verity Software House, Cytonome, USA). Immunofluorescence staining The method has previously been reported.23 Briefly, immunofluorescence staining was used to detect the cellular localization of CDK12 in osteoblasts. Cells were fixed with 4% paraformaldehyde for 20 minutes and permeated with 0.5% Triton X-100 (TBS) at room temperature. The cells were blocked with 2% bovine serum albumin (BSA) and 0.1% sodium azide in 0.1% Triton X-100 (TBS) for ten minutes at room temperature. Then, the cells were incubated with rabbit CDK12 antibody (Abcam, UK) overnight at 4°C. After overnight incubation, the cells were further incubated with the goat anti-rabbit Cy3-IgG secondary antibody for one hour. DAPI Staining Solution (Beyotime) was used to counterstain cell nuclei for ten minutes. Finally, the cells were enveloped with Fluoromount-G (Southern Biotech, USA) and were observed by fluorescence microscope (Leica, Germany). Real-time PCR We have reported the real-time PCR method in a previous study.23 The total RNA was extracted by Total RNA Kit I (Omega Bio-Tek, USA) according to the manufacturer’s instruction; 1 μg of total RNA was reverse transcribed into complementary DNA (cDNA) using PrimeScript RT reagent kit (Perfect Real Time) (TaKaRa, China). The expression of genes was detected by real-time PCR carried out in C1000 Thermal Cycler (Bio-Rad Labs, USA) with specific primers (Table I) and SYBR Premix Ex Taq (TaKaRa). The samples were amplified according to the following process: pre-denaturation at 95°C for 30 seconds, followed by 45 cycles of 95°C for ten seconds, 60°C for 30 seconds, 72°C for five seconds. Fluorescence detection was performed at the annealing phase at 80°C to exclude the interference of primer dimers. The relative expression of each gene was calculated by 2–∆∆CT method24 with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference. Table I.Primer sequences used for real-time polymerase chain reaction.Gene nameSequences (5’-3’)Annealing temperature (°C)CDK12F: CTGAATAACAGCGGGCAAAT60R: AGCTCTGGAGGTCGATACCACDT1F: GAATGCTGTGGAGCCTAGTAC60R: CTAGCACCTGATACTTGTAGGGCDC6F: TGGGAAGGACTTGATGAGAAAA60R: TTTCTCTAGCTTCAAGTCTCGGORC2F: TGATTCATGTCTTACGAAGCCT60R: AGAAAGTCCAATGTAGGAAGGGTOPBP1F: TCGCTCCTACCTAGACGCTTGC60R: CTCCATCTCATTGCCGCCAGTGGAPDHF: TGCACCACCAACTGCTTAG60R: GGATGCAGGGATGATGTTCCDC6, cell division control protein 6 homolog; CDK12, cyclin-dependent kinase 12; CDT1, chromatin licensing and DNA replication factor 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ORC2, origin recognition complex subunit 2; TOPBP1, topoisomerase II binding protein 1. Primer sequences used for real-time polymerase chain reaction. CDC6, cell division control protein 6 homolog; CDK12, cyclin-dependent kinase 12; CDT1, chromatin licensing and DNA replication factor 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ORC2, origin recognition complex subunit 2; TOPBP1, topoisomerase II binding protein 1. Western blot The method has previously been reported in our study.23 In brief, for western blot detection of protein levels, cellular total protein extracts were prepared on ice using Cell Lysis Buffer (Beyotime) supplemented with 1% protease inhibitor (Epizyme, China). The protein concentration was determined by BCA protein assay kit (Biosharp, China) and equal amount of proteins for each sample was subjected to 10% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and transblotted to nitrocellulose membrane or polyvinylidene fluoride (PVDF) membrane (PALL Corporation, USA). After incubation with the blocking buffer (5% non-fat milk), the membranes were incubated with appropriate primary antibodies against the following proteins in accordance with the manufacturer’s instructions: CDK12 (GeneTex, USA) and GAPDH (Proteintech, China) at 4°C overnight. Membranes were subsequently incubated with appropriate horseradish peroxidase-conjugated secondary antibodies (Cwbio, China). Protein bands were detected by an enhanced chemiluminescence (ECL) detection kit (Thermo Fisher Scientific) and visualized by a chemiluminescence imaging system. Statistical analysis All experiments were independently performed three times. The data were analyzed using GraphPad Prism v. 6.0 (GraphPad Software, USA) and all results were presented as mean (SD). The independent-samples t-test was used to conduct comparison between two groups, and the two-way analysis of variance (ANOVA) followed by Tukey’s post-hoc multiple-comparisons test was adopted for multiple group comparisons. Statistical significance was set at p < 0.05. Results Mechanical unloading inhibits osteoblast proliferation The primary murine osteoblasts were adopted to study the effect of mechanical unloading on osteoblast proliferation. The EdU staining assay showed that compared to the Control, mechanical unloading conducted by random positioning machine (RPM) dramatically reduced the EdU positive cell ratio after 24-hour and 48-hour treatment (Figures 1a, 1b, 1d and 1e). Meanwhile, the cell counting detection showed similar results that mechanical unloading significantly decreased the total cell number after 24-hour and 48-hour treatment (Figures 1c and 1f). These findings confirm that mechanical unloading inhibits osteoblast proliferation. Mechanical unloading (MU) inhibits osteoblast proliferation. a) Representative 5-ethynyl 2‘-deoxyuridine (EdU) staining images of murine primary osteoblasts in Control and MU group for 24 hours. Bar: 50 µm. b) EdU positive cell ratio in Control and MU group for 24 hours. c) Cell number detected by cell counting in Control and MU group for 24 hours. d) Representative EdU staining images of murine primary osteoblasts in Control and MU group for 48 hours. Bar: 50 µm. e) EdU positive cell ratio in Control and MU group for 48 hours. f) Cell number detected by cell counting in Control and MU group for 48 hours. Data are presented as mean (SD) and the independent-samples t-test was used for statistical analysis (n = 3). *p < 0.05, **p < 0.01. Mechanical unloading suppresses S phase progression As cell proliferation is closely related to the progression of cell cycle, the effect of mechanical unloading on cell cycle in primary osteoblasts was detected by flow cytometry. As shown in Figures 2a to 2d, significant decreases of S phase cell percentage were observed after 24-hour and 48-hour treatment of mechanical unloading, and 24-hour treatment also significantly increased the G1 phase cell population Figures 2a and 2b. These results reveal that mechanical unloading may inhibit osteoblast proliferation by suppressing S phase, during which the DNA replicates. Mechanical unloading (MU) reduces S phase cell percentage. a) Cell cycle of murine primary osteoblasts detected by flow cytometry (FCM) after 24-hour treatment of MU, with b) accompanying statistical analysis. c) Cell cycle of murine primary osteoblasts detected by FCM after 48-hour treatment of MU, with d) accompanying statistical analysis. Data are presented as mean (SD), and the two-way analysis of variance with Tukey’s post-hoc test was used for statistical analysis (n = 3). *p < 0.05, **p < 0.01. Mechanical unloading downregulates CDK12 expression The cyclin-dependent kinase (CDK) family plays an important role in regulating the cell cycle. CDK12, a member of CDK family, plays key roles in regulating the expression of DNA replication genes, cell cycle progression, and cell proliferation.10,25,26 Therefore, we detected the CDK12 expression of osteoblasts under mechanical unloading conditions. Real-time PCR and western blot analysis showed that mechanical unloading significantly decreased CDK12 mRNA and protein expression after 24-hour (Figures 3a to 3c) and 48-hour treatment (Figures 3d to 3f), which suggests that CDK12 may play a key role in mechanical unloading inhibiting osteoblast proliferation. Mechanical unloading (MU) downregulates cyclin-dependent kinase 12 (CDK12) expression. a) The expression of CDK12 in primary osteoblasts examined by real-time polymerase chain reaction (PCR) after 24-hour treatment of MU. b) Representative western blots of CDK12 in primary osteoblasts treated by 24-hour MU. c) Quantification analysis of western blots after 24-hour MU treatment. d) The expression of CDK12 in primary osteoblasts examined by real-time PCR after 48-hour treatment of MU. e) Representative western blots of CDK12 in primary osteoblasts treated by 48-hour MU. f) Quantification analysis of western blots after 48-hour MU treatment. Data are presented as mean (SD), and the independent-samples t-test was used for statistical analysis (n = 3). **p < 0.01, ***p < 0.001. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; mRNA, messenger RNA. CDK12 promotes osteoblast proliferation The regulatory role of CDK12 in osteoblast proliferation was initially investigated through loss and gain of function studies via knocking down and overexpressing CDK12 in MC3T3-E1 osteoblasts. Knockdown of CDK12 with small interfering RNA (siRNA) (si-CDK12) (Figures 4a to 4c) significantly reduced the EdU positive cells and total cell number (Figures 4d to 4f). Meanwhile, overexpression of CDK12 using pEGFP-N1-CDK12 plasmid (OV-CDK12) (Figures 4g to 4i) significantly increased the EdU positive cells and total cell number (Figures 4j to 4l). These findings confirm that CDK12 promotes osteoblast proliferation. Cyclin-dependent kinase 12 (CDK12) promotes osteoblast proliferation. a) The expression of CDK12 in MC3T3-E1 osteoblasts examined by real-time polymerase chain reaction (PCR) after treatment of small interfering RNA (si-CDK12). b) Representative western blots of CDK12 in MC3T3-E1 cells treated by si-CDK12. c) Quantification analysis of western blots after si-CDK12 treatment. d) Representative 5-ethynyl 2 ´-deoxyuridine (EdU) staining images of MC3T3-E1 cells in normal osteoblasts (Control) and si-CDK12 group. Bar: 50 µm. e) EdU positive cell ratio in Control and si-CDK12 group. f) Cell number detected by cell counting in Control and si-CDK12 group. g) The expression of CDK12 in MC3T3-E1 cells examined by real-time PCR after CDK12 overexpression. h) Representative western blots of CDK12 in MC3T3-E1 cells overexpressing CDK12. i) Quantification analysis of western blots after CDK12 overexpression (OV-CDK12) treatment. j) Representative EdU staining images of MC3T3-E1 cells in Control and OV-CDK12 group. Bar: 50 µm. k) EdU positive cell ratio in Control and OV-CDK12 group. l) Cell number detected by cell counting in Control and OV-CDK12 group. Data are presented as mean (SD), and the independent-samples t-test was used for statistical analysis (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001. CDK12 promotes S phase progression As CDK12 promotes osteoblast proliferation, the effect of CDK12 on the cell cycle of osteoblasts was further studied. The cell cycle analysis showed that CDK12 knockdown (si-CDK12) significantly reduced the S phase cell percentage (Figures 5a and 5b). In addition, overexpression of CDK12 dramatically increased the S phase cell percentage (Figures 5c and 5d). These results show the key role of CDK12 in regulating cell cycle in osteoblasts, and that CDK12 promotes osteoblast proliferation by increasing S phase cell percentage. Cyclin-dependent kinase 12 (CDK12) promotes S phase cell percentage. a) Cell cycle of MC3T3-E1 osteoblasts detected by flow cytometry (FCM) after knocking down CDK12 with CDK12-siRNA (si-CDK12). b) Statistical analysis of the same cell cycle. p = 0.049. c) Cell cycle of MC3T3-E1 osteoblasts detected by FCM after CDK12 overexpression (OV-CDK12). d) Statistical analysis of the same cell cycle. p = 0.047. Control: normal osteoblasts. Data are presented as mean (SD), and the two-way analysis of variance with Tukey’s post-hoc test was used for statistical analysis (n = 3). *p < 0.05. Mechanical unloading inhibits CDK12-mediated RNAPII transcription activation CDK12 regulates the expression of DNA replication genes by phosphorylating RNA polymerase II (RNAPII).10,26 Thus, we speculated that CDK12 may function in a similar way in mechanical unloading-induced inhibition of osteoblast proliferation. To test this theory, we detected the effects of mechanical unloading on the cellular localization of CDK12 in osteoblasts and on RNAPII, as well as the expression of downstream crucial DNA replication genes, including cell division cycle 6 (CDC6), DNA topoisomerase II binding protein 1 (TOPBP1), Cdc10-dependent transcript 1 (CDT1), and origin recognition complex subunit 2 (ORC2). As shown in Figure 6a, in the control osteoblasts, CDK12 was mainly localized in the nucleus, while in the osteoblasts treated by mechanical unloading, CDK12 was mainly distributed in the cytoplasm. In addition, the phosphorylation level of RNAPII ([P-Ser2] RNAPII) was significantly decreased (Figure 6b) in association with decreased expression of CDC6, TOPBP1, CDT1, and ORC2 by mechanical unloading (Figure 6c). These data suggest that CDK12 regulates cell proliferation by regulating the expression of DNA replication genes by regulating the RNAPII phosphorylation. We further verified this working mechanism of CDK12 by knockdown of CDK12 and overexpression of CDK12 in osteoblasts, respectively. The results showed that CDK12 knockdown (si-CDK12) significantly reduced the amount of nuclear CDK12 (Figure 6d). In addition, CDK12 knockdown significantly reduced the [P-Ser2] RNAPII level (Figure 6e) and the expression of CDC6, TOPBP1, CDT1, and ORC2 (Figure 6f). Meanwhile, overexpression of CDK12 promoted nuclear localization of CDK12 (Figure 6g), increased the [P-Ser2] RNAPII level (Figure 6h) and upregulated the expression of CDC6, TOPBP1, CDT1, and ORC2 (Figure 6i). All these findings demonstrate that CDK12 participates in mechanical unloading-induced inhibition of osteoblast proliferation by regulating the expression of DNA replication genes via regulating RNAPII phosphorylation (Figure 7). Mechanical unloading (MU) inhibits cyclin-dependent kinase 12 (CDK12)-mediated RNA polymerase II (RNAPII) transcription activity, leading to reduced expression of DNA replication genes. a) Representative images of CDK12 localization in murine primary osteoblasts after MU treatment. Bar: 50 µm. b) Representative western blots of P-Ser2 RNAPII and RNAPII in primary osteoblasts treated by MU. c) The expression of cell division cycle 6 (CDC6), Cdc10-dependent transcript 1 (CDT1), origin recognition complex subunit 2 (ORC2), and DNA topoisomerase II binding protein 1 (TOPBP1) in primary osteoblasts after MU treatment. d) Representative images of CDK12 localization in MC3T3-E1 cells after si-CDK12 treatment. Bar: 50 µm. e) Representative western blots of P-Ser2 RNAPII and RNAPII in MC3T3-E1 cells treated by si-CDK12. f) The expression of CDC6, CDT1, ORC2, and TOPBP1 in MC3T3-E1 cells after si-CDK12 treatment. g) Representative images of CDK12 localization in MC3T3-E1 cells after CDK12 overexpression. Bar: 50 µm. h) Representative western blots of P-Ser2 RNAPII and RNAPII in MC3T3-E1 cells overexpressing CDK12. i) The expression of CDC6, CDT1, ORC2, and TOPBP1 after CDK12 overexpression. a) to c): Control: normal condition. MU: mechanical unloading. d) to f): Control: normal osteoblasts, si-CDK12: osteoblasts knocking down CDK12. g) to i): Control: normal osteoblasts, OV-CDK12: osteoblasts overexpressing CDK12. Data are presented as mean (SD), and the independent-samples t-test was used for statistical analysis (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001. Proposed model of cyclin-dependent kinase 12 (CDK12) mediates the inhibition effect of mechanical unloading on osteoblast proliferation by regulating RNA polymerase II (RNAPII) transcription activation. CDK12 is expressed at normal level in osteoblasts under normal conditions and translocates into the nucleus to phosphorylate RNAPII, thereby inducing the expression of DNA replication genes, which maintains normal osteoblast proliferation. Meanwhile, mechanical unloading conditions decrease the CDK12 level, reduces CDK12 nuclear translocation, inhibits RNAPII phosphorylation, and suppresses the expression of DNA replication genes, which inhibits osteoblast proliferation. Cyclin-dependent kinase 12 (CDK12) overexpression shows rescue effects on the decreased osteoblast proliferation induced by mechanical unloading (MU). a) Representative 5-ethynyl 2´-deoxyuridine (EdU) staining images of murine primary osteoblasts in the different groups as indicated. Bar: 50 µm. b) EdU-positive cell ratio in different groups as indicated. c) Total cell number of murine primary osteoblasts in different groups as indicated. d) Cell cycle analysis by flow cytometry in different groups. e) Statistical analysis of the same cell cycle presented. Control: normal osteoblasts cultured under normal conditions; Control-OV-CDK12: osteoblasts overexpressing CDK12 cultured under normal conditions; MU: normal osteoblasts cultured under mechanical unloading conditions, MU-OV-CDK12: osteoblasts overexpressing CDK12 cultured under mechanical unloading conditions. Data are presented as mean (SD), and the two-way analysis of variance with Tukey’s post-hoc test was used for statistical analysis (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001. Overexpression of CDK12 rescues the decreased osteoblast proliferation induced by mechanical unloading Given the role of CDK12 as a positive regulator of osteoblast proliferation, we theorized that the overexpression of CDK12 could rescue the decreased osteoblast proliferation under mechanical unloading conditions. To determine this, osteoblasts overexpressing CDK12 were cultured under mechanical unloading conditions. The results show that CDK12 overexpression (OV-CDK12) significantly increased EdU-positive cells and total cell number in both control osteoblasts and osteoblasts treated by mechanical unloading (Figures 8a to 8c). The decrease of EdU-positive cells and cell number by mechanical unloading was restored to almost normal levels by CDK12 overexpression (Figures 8a to 8c). Moreover, CDK12 overexpression showed rescue effects on the reduction of S phase cell percentage induced by mechanical unloading (Figures 8d and 8e). These results demonstrate the rescue effect of CDK12 overexpression on decreased osteoblast proliferation induced by mechanical unloading, indicating CDK12 as a novel potential target for treating bone disease related to osteoblast proliferation. Discussion Decreased osteoblast proliferation is one of the primary causes of osteoporosis induced by mechanical unloading conditions, such as being bedridden, subject to prolonged immobilization, and long-term spaceflight. However, the underlying mechanism is still unclear. The present study shows that mechanical unloading inhibits osteoblast proliferation and reduces S phase percentage associated with decreased CDK12 expression, revealing the important role of CDK12 in mechanical unloading-induced inhibition of osteoblast proliferation. Loss and gain of function studies show that CDK12 promotes osteoblast proliferation. Mechanical unloading inhibits osteoblast proliferation by downregulating CDK12 expression, which inactivates RNAPII and downregulates the expression of DNA replication genes. Further overexpression of CDK12 rescues the decreased osteoblast proliferation and reduced S phase percentage induced by mechanical unloading, demonstrating CDK12 as a novel target for modifying osteoblast proliferation to treat bone diseases. This study expands the knowledge base about CDK12 biological functions, contributes to a novel mechanistic insight of the inhibitory effects of mechanical unloading on osteoblast proliferation, and provides a new target for treating disuse osteoporosis. In light of these findings, we proposed a model in which CDK12 participates in mechanical unloading inhibiting osteoblast proliferation (Figure 7). Osteoblasts are bone-forming cells that are responsible for maintaining bone homeostasis. Osteoblasts are sensitive to mechanical stimuli and alter their functions to adapt accordingly. Decreased osteoblast proliferation is believed to be one major cause of osteoporosis induced by mechanical unloading.8,9 Here, consistent with previous findings, our results confirm that mechanical unloading inhibits osteoblast proliferation. As the cell cycle is closely related to cell proliferation, we further investigated the effects of mechanical unloading on the cell cycle of osteoblasts. The results showed a reduction of S phase cell percentage under mechanical unloading conditions, suggesting that mechanical unloading inhibits osteoblast proliferation by altering cell cycle progression. Given the role of CDK12 in cell proliferation and cell cycle, we hypothesized that CDK12 may be involved in mechanical unloading-induced inhibition of osteoblast proliferation. We found that mechanical unloading significantly downregulated CDK12 expression. Moreover, CDK12 knockdown significantly reduced the EdU-positive cells and total cell number, while overexpression of CDK12 dramatically increased the EdU-positive cells and total cell number, demonstrating that CDK12 promotes osteoblast proliferation. This is consistent with previous findings that CDK12 positively regulates cell proliferation.18,27,28 In addition, cell cycle analysis showed that CDK12 knockdown significantly reduced the S phase cell percentage while its overexpression increased S phase cell percentage. Studies have shown that CDK12 is critical in controlling G1/S progression and CDK12 inhibition causes G1/S progression delay, presenting as a reduction in S phase percentage.10,26 Our findings also showed a reduced S phase after CDK12 knockdown, but an increase in S phase after CDK12 overexpression. All these results reveal that CDK12 promotes osteoblast proliferationby regulating cell cycle progression. The decreased osteoblast proliferation and reduced S phase percentage due to CDK12 knockdown were similar to the effects of mechanical unloading on osteoblast proliferation and cell cycle. As mechanical unloading suppresses CDK12 expression, these findings confirm the critical involvement of CDK12 in mechanical unloading inhibiting osteoblast proliferation. Interestingly, our previous study has shown that CDK12 inhibits osteoblast differentiation.21 As osteoblast proliferation and differentiation are two distinct sequential stages that are fundamentally divergent and somewhat antagonistic in nature, many molecules exhibit opposite roles in these two different stages. Hilton et al29 have reported that Notch promotes osteoblast progenitors’ proliferation but inhibits osteoblast differentiation. Moreover, Bialek et al30 have also reported that Twist shows a promotion effect on osteoblast proliferation but an inhibitory effect on osteoblast differentiation. All these findings are consistent with our results, demonstrating stage-specific roles of CDK12 in osteoblast proliferation and differentiation. Other studies have shown that CDK12 is associated with RNAPII to regulate gene expression to control cell proliferation and cell cycle progression.10,15,26,31 Thus, we theorized that CDK12 functions in a similar way during mechanical unloading inhibiting osteoblast proliferation. To test this hypothesis, we detected the cellular localization of CDK12 in osteoblasts. The immunofluorescence staining showed that in the Control osteoblasts, CDK12 was mainly localized in the nucleus, while in the osteoblasts treated by mechanical unloading, CDK12 was mainly distributed in the cytoplasm. As CDK12 phosphorylates Serine 2 (Ser2) of RNAPII to regulate downstream target gene expression,11,15,32 we then detected the expression and phosphorylation of RNAPII ([P-Ser2] RNAPII) in osteoblasts treated by mechanical unloading. The results showed that compared to the Control, the [P-Ser2] RNAPII was significantly inhibited by mechanical unloading, suggesting inactivation of RNAPII. Chirackal Manavalan et al10 have reported that CDK12 is required for transcription of core DNA replication genes to affect cell cycle and cell proliferation. Inhibition of CDK12 caused G1/S cell cycle progression delay due to inactivation of RNAPII and decreased expression of core DNA replication genes, including CDC6, CDT1, ORC2, and TOPBP1.10 Our study shows similar results in osteoblasts treated by mechanical unloading, with mechanical unloading dramatically downregulating the expression of CDC6, CDT1, ORC2, and TOPBP1. As mechanical unloading downregulates CDK12 expression, these findings reveal that the effects of mechanical unloading on [P-Ser2] RNAPII and the expression of downstream CDC6, CDT1, ORC2, and TOPBP1 genes were mediated by CDK12. To verify this, the effects of CDK12 on cellular localization of itself, [P-Ser2] RNAPII and the expression of CDC6, CDT1, ORC2, and TOPBP1 were investigated by knockdown of CDK12 and overexpressing CDK12 in osteoblasts, respectively. Similar results with mechanical unloading treatment were observed in CDK12 knockdown osteoblasts, showing reduced nuclear localization of CDK12 and decreased [P-Ser2] RNAPII and CDC6, CDT1, ORC2, and TOPBP1 expression. In contrast, CDK12 overexpression increased the nuclear localization of CDK12 and upregulated [P-Ser2] RNAPII level and the expression of CDC6, CDT1, ORC2, and TOPBP1. All these demonstrate that mechanical unloading suppresses osteoblast proliferation by inhibiting CDK12-mediated RNAPII transcription activation on core DNA replication genes. Data from the Human Protein Atlas indicate that CDK12 expression is markedly enriched in bone marrow compared with other tissues, implying that it has a critical biological role in skeletal tissues.25 CDK12 is indispensable for mammalian development and cellular viability, as global deletion of CDK12 in mice results in impaired cell proliferation at the blastocyst stage and early embryonic lethality.33 In addition, recent studies have shown that CDK12 is a driver gene of human gastric cancer growth, and that knockdown of CDK12 or treatment with the CDK12 inhibitor procaterol can significantly inhibit cancer cell proliferation and tumour growth in human gastric cancer cells and patient-derived xenografts.34,35 Collectively, our findings are consistent with these in vivo observations, demonstrating that CDK12 promotes cell proliferation. All of the above findings demonstrate the important role of CDK12 in regulating osteoblast proliferation and in mechanical unloading inhibiting osteoblast proliferation. Moreover, the results indicate CDK12 as a potential target for treating decreased osteoblast proliferation. To test the potential of CDK12 as a therapeutic target, we detected the effects of CDK12 overexpression on osteoblast proliferation under both Control and mechanical unloading conditions. The results showed that CDK12 overexpression significantly increased cell proliferation in both Control osteoblasts and osteoblasts treated by mechanical unloading. The decreased cell proliferation induced by mechanical unloading was restored to near-normal levels by CDK12 overexpression. Moreover, CDK12 overexpression showed rescue effects on the reduced S phase. Previous studies have shown that CDK12 is a potential target for treating cancer.25,36-38 Here, our study extends CDK12 as a potential target for treating bone diseases.